Evidence and support

TMS and other specialist non-drug options

Non-drug treatment is broader than lifestyle. TMS is being studied for PPD; the cited SAINT trial is recruiting, not a completed result. Severe illness may need specialist interventions.

Research preview · selected sources rechecked September 14, 2026 · independent clinical review pending. These editorial assessments are not formal GRADE ratings. No study here establishes an effect of Brighter Postpartum.

The important distinction

Ongoing trials are not proof of efficacy, and non-drug does not mean self-directed or risk-free.

limitedresearch-status · C38

Accelerated TMS for PPD remains a research question in an ongoing trial

Population and setting: Planned 192 adults with PPD not improved with standard care; multi-site sham-controlled trial.
What was found: Mount Sinai lists the SAINT study as recruiting, with completion planned for 2029.
Limits and applicability: A recruitment page is not an efficacy result. No promised remission rate or home device protocol follows from it.

Sources: S63

supportedtreatment · C36

ECT remains a specialist option for severe illness

Population and setting: Severe postpartum psychosis or other life-threatening/refractory presentations.
What was found: Guidance includes ECT in selected severe cases; 2026 review summarizes a limited predominantly nonrandomized literature.
Limits and applicability: Not an outpatient self-help intervention. Urgency and specialist judgment matter more than app engagement.

Sources: S40 · S60

Should an app prescribe a brain-stimulation protocol?

No. The role here is accurate education and practical help reaching qualified care.

Use this as information, not an assessment

Symptoms or concerns deserve appropriate professional care. Severe or worsening symptoms should not wait for an app, a quiz or a two-week threshold.